Randomized, double-blind, placebo-controlled split-face trial of the efficacy of tranexamic acid by drug delivery through microneedling in the treatment of melasma.
Kuster Kaminski Arida D, Orso Rebellato PR, Marioto de Campos GL, Costa A, Vilaverde Schmitt J, Larocca Skare T, Rodrigues Lisboa Faucz L.
Kuster Kaminski Arida D, et al.
J Cosmet Dermatol. 2021 Dec;20(12):4005-4010. doi: 10.1111/jocd.14257. Epub 2021 Jun 18.
J Cosmet Dermatol. 2021.
PMID: 34077619
Clinical Trial.
BACKGROUND: Melasma is a prevalent skin pigmentation disorder that is difficult to treat. Tranexamic acid (TA) is a potential agent, but there are few studies on its effectiveness under the transdermal route (drug delivery-Dd). ...OBJECTIVE: To evaluate the e …
BACKGROUND: Melasma is a prevalent skin pigmentation disorder that is difficult to treat. Tranexamic acid (TA) is a pot …